Top Markets
Coin of the day
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Ранг среди акций #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Цена акции
$0.00023723
Последняя синхронизация: 2024-08-26
Рыночная капитализация
$1.41K
Изменение (1 день)
111.67%
Изменение (1 год)
0.00%
Страна
FR
Торговля Pharnext S.A. (ALPHA)

Категория

История дивидендов Pharnext S.A. (ALPHA)
Pharnext S.A. (тикер: ALPHA) выплатила в общей сложности 1 дивидендов.
Общая сумма всех дивидендов (с учетом дроблений акций): $0.20
Дивидендная доходность (TTM): 0
Дивидендные выплаты по Pharnext S.A. (ALPHA) с 2024 по 2026
Годовые дивидендные выплаты
Год Дивиденды (с учетом дробления акций) Изменить
2026 (TTM) $0.2 0.00%
2024 $0.2 0.00%
Список всех дивидендных выплат
Год Дивиденд Изменить
2026 (TTM) $0.2 0.00%
2024 $0.2 0.00%
Дивиденды аналогичных компаний или конкурентов
Компания Количество дивидендных выплат Страна
0.00%
US
0.00%
NL
0.00%
CH
29.00%
BE
0.00%
KR